Deerfield gives up rights to Windtree therapy; Travere inks deal with Renalys in Asia; Celularity raises $21M
Plus, news about Prime Medicine, Sagimet Biosciences and Adicet Bio:
Deerfield terminates rights to 2017 deal with Windtree Therapeutics: The biotech last year in-licensed Aerosurf …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
